| Andrew David Skorheim, PHARMD | |
|
26501 Avenue 140 Apt 30, Porterville, CA 93257-9109 | |
| (562) 822-1279 | |
| Not Available |
| Full Name | Andrew David Skorheim |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 26501 Avenue 140 Apt 30, Porterville, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053978593 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | S023816 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrew David Skorheim, PHARMD Po Box 2647, Porterville, CA 93258-2647 Ph: (562) 822-1279 | Andrew David Skorheim, PHARMD 26501 Avenue 140 Apt 30, Porterville, CA 93257-9109 Ph: (562) 822-1279 |
News Archive
A clinical trial of an experimental drug for treatment-resistant major depression finds that modulation of the endogenous opioid system may improve the effectiveness of drugs that target the action of serotonin and related monoamine neurotransmitters.
The Association for Cancer Physicians, which represents and supports medical oncologists in the UK, has published a new Strategy for improving cancer patient services and outcomes.
Melanoma is one of the less common types of skin cancer but it accounts for the majority of the skin cancer deaths (about 75 percent).The five-year survival rate for early stage melanoma is very high (98 percent), but the rate drops precipitously if the cancer is detected late or there is recurrence.So a great deal rides on the accuracy of the initial surgery, where the goal is to remove as little tissue as possible while obtaining "clean margins" all around the tumor.So far no imaging technique has been up to the task of defining the melanoma's boundaries accurately enough to guide surgery.Instead surgeons tend to cut well beyond the visible margins of the lesion in order to be certain they remove all the malignant tissue.Two scientists at Washington University in St. Louis have developed technologies that together promise to solve this difficult problem.
Sanofi-aventis announced today results of a head-to-head study providing further evidence on the efficacy of once-daily, 24-hour basal insulin Lantus(R) (insulin glargine (rDNA) injection) compared to twice-daily insulin detemir. The study was presented during the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna.
› Verified 7 days ago
Lauren Skorheim, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26501 Avenue 140, Porterville, CA 93257 Phone: 559-782-2222 | |
Lana Thao Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 66 W Morton Ave, Porterville, CA 93257 Phone: 559-788-0452 | |
Spencer C Pantera, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 53 E Olive Ave, Porterville, CA 93257 Phone: 559-791-9238 | |
Cheng Chang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 N Westwood St, Porterville, CA 93257 Phone: 559-784-2876 | |
Parmbir Singh Kahlon, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1250 W Henderson Ave, Wal-mart Pharmacy, Porterville, CA 93257 Phone: 559-783-8195 | |
Cindy Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1250 W Henderson Ave, Porterville, CA 93257 Phone: 559-783-2090 Fax: 559-783-2092 |